| Cisplatin | Approved Investigational | SERPINB5 | 5268 |
upregulated | Cisplatin results in increased expression of SERPINB5 mRNA | 18q21.33 | |
| Cisplatin | Approved Investigational | SERPINB8 | 5271 |
upregulated | Cisplatin results in increased expression of SERPINB8 mRNA | 18q22.1 | |
| Cisplatin | Approved Investigational | SERPINE1 | 5054 |
upregulated | Cisplatin results in increased expression of SERPINE1 mRNA | 7q22.1 | |
| Cisplatin | Approved Investigational | SERPINE2 | 5270 |
upregulated | Cisplatin results in increased expression of SERPINE2 mRNA | 2q36.1 | |
| Cisplatin | Approved Investigational | SERTAD1 | 29950 |
upregulated | Cisplatin results in increased expression of SERTAD1 mRNA | 19q13.1-q13.2 | |
| Cisplatin | Approved Investigational | SESN1 | 27244 |
upregulated | Cisplatin results in increased expression of SESN1 mRNA | 6q21 | |
| Cisplatin | Approved Investigational | SESN2 | 83667 |
upregulated | Cisplatin results in increased expression of SESN2 mRNA | 1p35.3 | |
| Cisplatin | Approved Investigational | SETMAR | 6419 |
upregulated | Cisplatin results in increased expression of SETMAR mRNA | 3p26.1 | |
| Cisplatin | Approved Investigational | SFN | 2810 |
upregulated | Cisplatin results in increased expression of SFN mRNA | 1p36.11 | |
| Cisplatin | Approved Investigational | SH3RF2 | 153769 |
downregulated | Cisplatin results in decreased expression of SH3RF2 mRNA | 5q32 | |
| Cisplatin | Approved Investigational | SIAH2 | 6478 |
upregulated | Cisplatin results in increased expression of SIAH2 mRNA | 3q25.1 | |
| Cisplatin | Approved Investigational | SIK3 | 23387 |
downregulated | Cisplatin results in decreased expression of SIK3 mRNA | 11q23.3 | |
| Cisplatin | Approved Investigational | SIL1 | 64374 |
downregulated | Cisplatin results in decreased expression of SIL1 mRNA | 5q31.2 | |
| Cisplatin | Approved Investigational | SIPA1L1 | 26037 |
downregulated | Cisplatin results in decreased expression of SIPA1L1 mRNA | 14q24.1 | |
| Cisplatin | Approved Investigational | SIVA1 | 10572 |
upregulated | Cisplatin results in increased expression of SIVA1 mRNA | 14q32.33 | |
| Cisplatin | Approved Investigational | SKAP2 | 8935 |
downregulated | Cisplatin results in decreased expression of SKAP2 mRNA | 7p15.2 | |
| Cisplatin | Approved Investigational | SLBP | 7884 |
downregulated | Cisplatin results in decreased expression of SLBP mRNA | 4p16.3 | |
| Cisplatin | Approved Investigational | SLC12A8 | 84561 |
downregulated | Cisplatin results in decreased expression of SLC12A8 mRNA | 3q21.2 | |
| Cisplatin | Approved Investigational | SLC1A4 | 6509 |
downregulated | Cisplatin results in decreased expression of SLC1A4 mRNA | 2p14 | |
| Cisplatin | Approved Investigational | SLC1A5 | 6510 |
downregulated | Cisplatin results in decreased expression of SLC1A5 mRNA | 19q13.32 | |
| Cisplatin | Approved Investigational | SLC1A5 | 6510 |
upregulated | Cisplatin results in increased expression of SLC1A5 mRNA | 19q13.32 | |
| Cisplatin | Approved Investigational | SLC1A7 | 6512 |
upregulated | Cisplatin results in increased expression of SLC1A7 mRNA | 1p32.3 | |
| Cisplatin | Approved Investigational | SLC20A1 | 6574 |
downregulated | Cisplatin results in decreased expression of SLC20A1 mRNA | 2q14.1 | |
| Cisplatin | Approved Investigational | SLC22A5 | 6584 |
downregulated | Cisplatin results in decreased expression of SLC22A5 mRNA | 5q31.1 | |
| Cisplatin | Approved Investigational | SLC25A13 | 10165 |
downregulated | Cisplatin results in decreased expression of SLC25A13 mRNA | 7q21.3 | |